By Josh White
Date: Wednesday 22 Oct 2025
(Sharecast News) - Novacyt said on Wednesday that it expects improved second-half performance in 2025, as it outlined a new growth strategy focused on accelerating product development, achieving sustained double-digit revenue growth, and returning to EBITDA profitability.
By Josh White
Date: Friday 12 Sep 2025
(Sharecast News) - Novacyt said on Friday that its Lab 21 Healthcare subsidiary has been fined £52,000 following the conclusion of a Health and Safety Executive prosecution relating to historical operations at its former Axminster site.
By Josh White
Date: Thursday 30 Jan 2025
(Sharecast News) - Novacyt reported strong revenue growth for 2024 in an update on Thursday, with unaudited statutory revenue reaching about £19.6m, an 85% increase from the prior year's £10.6m.
| Currency | UK Pounds |
| Share Price | 35.70p |
| Change Today | -0.25p |
| % Change | -0.70 % |
| 52 Week High | 62.10 |
| 52 Week Low | 34.90 |
| Volume | 77,329 |
| Shares Issued | 70.63m |
| Market Cap | £25.21m |
| Beta | 0.98 |
| RiskGrade | 453 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:35 | 9,686 @ 35.70p |
| 16:35 | 2,435 @ 35.70p |
| 16:35 | 2,428 @ 35.70p |
| 16:35 | 2,415 @ 35.70p |
| 16:35 | 1,230 @ 35.70p |
You are here: research